Author Rudolph, C.
-
2000 | Journal Article
MPH1, a yeast gene encoding a DEAH protein, plays a role in protection of the genome from spontaneous and chemically induced damage
Scheller, J.; Schurer, A.; Rudolph, C.; Hettwer, S. & Kramer, W. (2000)
Genetics, 155(3) pp. 1069-1081.
Details PMID PMC WoS
-
2003 | Conference Abstract
Genetic interactions of mph1 mutants from Saccharomyces cerevisiae imploy an involvement in error free bypass of DNA lesions.
Schurer, K. A.; Rudolph, C. & Kramer, W. (2003)
Yeast, 20 21st International Conference on Yeast Genetics and Molecular Biology, GOTHENBURG, SWEDEN.
Chichester: John Wiley & Sons Ltd.
Details WoS
-
2003 | Journal Article
Practicability and acute haematological toxicity of 2-and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
Wunderlich, A.; Kloess, M.; Reiser, M.; Rudolph, C.; Truemper, L. H.; Bittner, S. & Schmalenberg, H. et al. (2003)
Annals of Oncology, 14(6) pp. 881-893. DOI: https://doi.org/10.1093/annonc/mdg249
Details DOI PMID PMC WoS
-
2004 | Journal Article
Yeast MPH1 gene functions in an error-free DNA damage bypass pathway that requires genes from homologous recombination, but not from postreplicative repair
Schurer, K. A.; Rudolph, C.; Ulrich, H. D. & Kramer, W. (2004)
Genetics, 166(4) pp. 1673-1686. DOI: https://doi.org/10.1534/genetics.166.4.1673
Details DOI PMID PMC WoS
-
2004 | Journal Article
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL
Pfreundschuh, M.; Truemper, L. H.; Kloess, M.; Schmits, R.; Feller, A. C.; Rube, C. & Rudolph, C. et al. (2004)
Blood, 104(3) pp. 634-641. DOI: https://doi.org/10.1182/blood-2003-06-2095
Details DOI PMID PMC WoS
-
2004 | Journal Article
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL
Pfreundschuh, M.; Truemper, L. H.; Kloess, M.; Schmits, R.; Feller, A. C.; Rudolph, C. & Reiser, M. et al. (2004)
Blood, 104(3) pp. 626-633. DOI: https://doi.org/10.1182/blood-2003-06-2094
Details DOI PMID PMC WoS
-
2009 | Journal Article
Sonographische Humerustorsionsmessungen bei Kindern und Jugendlichen mit spastischer Hemiparese
Katthagen, J. C.; Rudolph, C. & Hell, A. K. (2009)
Der Orthopäde, 38(10) pp. 956-961. DOI: https://doi.org/10.1007/s00132-009-1438-2
Details DOI PMID PMC WoS
-
2015 | Conference Abstract
CLINICAL OUTCOME IN OLDER AML PATIENTS NOT FIT FOR INTENSIVE CHEMOTHERAPY: RESULTS OF THE POPULATION-BASED AMLSG-BIO (NCT01252485) REGISTRY STUDY OF THE GERMAN-AUSTRIAN AML STUDY GROUP
Schlenk, R. F.; Paschka, P.; Krauter, J.; Luebbert, M.; Brossart, P.; Salih, H. R. & Theobald, M. et al. (2015)
Haematologica, 100 pp. 193-194. 20th Congress of European-Hematology-Association, Vienna, AUSTRIA.
Pavia: Ferrata Storti Foundation.
Details WoS
-
2017 | Journal Article
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)
Nagel, G.; Weber, D.; Fromm, E.; Erhardt, S.; Lübbert, M.; Fiedler, W. & Kindler, T. et al. (2017)
Annals of Hematology, 96(12) pp. 1993-2003. DOI: https://doi.org/10.1007/s00277-017-3150-3
Details DOI